Home
Drugs
Vinorelbine
Clinical Trials

Clinical Trials Related to Vinorelbine

Related studies linked through entity extraction aliases.

A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine

Status: COMPLETED
Phase: PHASE3

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

Status: COMPLETED
Phase: PHASE1

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

Vinorelbine and Gemcitabine in Myeloma

Status: COMPLETED
Phase: PHASE2

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Status: UNKNOWN
Phase: PHASE2

A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease

Status: TERMINATED
Phase: PHASE3

Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC

Status: COMPLETED
Phase: PHASE2

Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Status: COMPLETED
Phase: PHASE2

Platinum Rechallenge in Patients With Platinum-sensitive mTNBC

Status: UNKNOWN
Phase: PHASE2

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.

Status: TERMINATED
Phase: PHASE2

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Status: UNKNOWN
Phase: PHASE3

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)

Status: COMPLETED
Phase: PHASE3

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)

Status: COMPLETED
Phase: PHASE3

Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM

Status: COMPLETED
Phase: PHASE1

Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer

Status: UNKNOWN
Phase: PHASE2

A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer

Status: COMPLETED
Phase: PHASE3

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Status: COMPLETED
Phase: PHASE4

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Status: COMPLETED
Phase: PHASE2